EUVIMEDEUVIMED entdecken
Crossref

Analysis of patch testing with cocamidopropyl betaine and its impurities in patients with intractable scalp dermatitis in a single clinic in Japan

Shigeruko Iijima iD, Kayo Murayama, Noriko Takayama, Takumi Akiyama, Yoshiaki Ikarashi, Mariko Sugiyama, Kayoko Matsunaga

Contact Dermatitis · 2023

DOI: 10.1111/cod.14393 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Contact Dermatitis, 2023. Verfasst von Shigeruko Iijima und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Hanamizuki Clinic, Ushiku, Ibaraki, Japan. Hauptthemen laut MEDLINE: Dermatitis, Allergic Contact. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Hoyu Co., Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The allergen responsible for cocamidopropyl betaine (CAPB) allergies has been debated.

Objectives

To investigate the sensitizing agents of CAPB, the patch test positivity rates of impurities were examined in Japanese patients with CAPB‐related allergic contact dermatitis. Materials and Methods Thirty patients with scalp dermatitis and positive patch tests for CAPB and/or lauramidopropyl betaine (LAPB) were enrolled in this study. They were patch tested with the detergents that they had been using at the time of their first visit and with the impurities dimethylaminopropylamine (DMAPA) and lauramidopropyl dimethylamine (LAPDMA).

Results

The positivity rate in patch tests of the 37 detergents that the patients had been using was 78.4% (29/37). The positivity rates of DMAPA 1% pet., 1% aq. and 0.2% aq. were 32.1% (9/28), 14.3% (4/28) and 13.3% (4/30), respectively, whereas those of LAPDMA 0.1% and 0.05% were 30.0% (9/30) and 16.7% (5/30), respectively. Among the 30 patients, 6 exhibited positive results for both DMAPA and LAPDMA, 3 showed positive results for DMAPA alone and 6 produced positive results for LAPDMA alone.

Conclusion

Patch tests produced an overall positivity rate for DMAPA, LAPDMA or both of 50.0% (15/30) in patients with scalp dermatitis and positive patch test results for CAPB and/or LAPB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, Allergic ContactHumansPatch TestsBetaineDetergentsJapanScalpDiaminesAllergensSurface-Active AgentsArsenicals

Stichwörter der Autor:innen

CAS RN: 109-55-7CAS RN: 3179-80-4CAS RN: 61789-40-0allergic contact dermatitiscocamidopropyl betainedimethylaminopropylamineimpuritieslauramidopropyl dimethylamine

Substanzen

BetaineDetergentsDiaminesAllergensSurface-Active Agentscocamidopropyl betainedimethylarsinopenicillamineArsenicals

Autor:innen und Institutionen

  • Division of Dermatology, Hanamizuki Clinic, Ushiku, Ibaraki, Japan.
  • Division of Gynecology, Hanamizuki Clinic, Ushiku, Ibaraki, Japan.
  • Division of Environmental Chemistry, National Institute of Health Sciences, Kawasaki, Kanagawa, Japan.
  • Department of Integrative Medical Science for Allergic Disease, Fujita Health University School of Medicine, Nagoya, Aichi, Japan.
  • The Association of SSCI-Net, Nagoya, Aichi, Japan.

ORCID-Profile: Shigeruko Iijima

Förderung

  • Hoyu Co., Ltd.

Zitieren

APA

Iijima, S., Murayama, K., Takayama, N., Akiyama, T., Ikarashi, Y., Sugiyama, M., & Matsunaga, K. (2023). Analysis of patch testing with cocamidopropyl betaine and its impurities in patients with intractable scalp dermatitis in a single clinic in Japan. Contact Dermatitis. https://doi.org/10.1111/cod.14393

Vancouver

Iijima S, Murayama K, Takayama N, Akiyama T, Ikarashi Y, Sugiyama M, et al. Analysis of patch testing with cocamidopropyl betaine and its impurities in patients with intractable scalp dermatitis in a single clinic in Japan. Contact Dermatitis. 2023. doi:10.1111/cod.14393

BibTeX
@article{Iijima2023,
  author = {Iijima, Shigeruko and Murayama, Kayo and Takayama, Noriko and Akiyama, Takumi and Ikarashi, Yoshiaki and Sugiyama, Mariko and Matsunaga, Kayoko},
  title = {Analysis of patch testing with cocamidopropyl betaine and its impurities in patients with intractable scalp dermatitis in a single clinic in Japan},
  journal = {Contact Dermatitis},
  year = {2023},
  doi = {10.1111/cod.14393}
}
Kostenlos starten →